speb/financial-data huggingface dataset:
Financial ratios for 9301.T — annual report dated 2025-03-31
Total revenue: 1898576393.5302765
Gross profit: 243516909.504077
Operating income: 135750568.1058682
Net income: 215358909.23673305
Capital expenditures: 0
Operating cash flow: 197981553.26827964
Depreciation & amortization: 118259590.96377489
Net tangible assets: 2234460633.605133
Owner earnings: 333618500.20050794
Return on net tangible assets (%): 14.930605407992342
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.273827028472129
P/E ratio: 9.927568601727392
Shares outstanding: 340779294
Book value: 2534901751.1027937
P/B ratio: 0.8434213848764475
Market cap (USD): 2137990345.4408503
Debt to equity: 0.2902191567002046
Current ratio: 1.3512634449000622
Quick ratio: 1.3086476738444364
Effective tax rate (%): 34.538030229156504
Interest coverage ratio: 23.265750286368842
COGS to revenue (%): 87.17406227447944
Free cash flow (dilution-adjusted): 197981553.26827964
Buyback yield (%): 6.268480884081712
Retained earnings: 1850401015.9069643
Inventory turnover: 62.37556675062972
Receivables turnover: 6.983087096536297
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.811409270031901
FCF margin (%): 10.427895024026192
Revenue growth (%): 12.972844841819796
Rule of 40 score: 23.40073986584599
Financial ratios for 9301.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.942706891779685
Shares outstanding: 340779294
Market cap (USD): 2706710047.0296154
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9301.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 2261029609.6904445
Buffett classification: The Gruesome
Stock price: 8.040174966352625
Shares outstanding: 340779294
Book value: 2544111709.2866755
P/B ratio: 1.0769673118789067
Market cap (USD): 2739925148.670121
Debt to equity: 0.3063337345095291
Current ratio: 1.4839685032639935
Quick ratio: 1.3449255852217485
Buyback yield (%): 0
Retained earnings: 1988371467.025572
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9626.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.23076923076923
Shares outstanding: 338805755
Market cap (USD): 15663250673.46154
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9626.HK — annual report dated 2022-12-31
Total revenue: 3146432040.229885
Gross profit: 553059626.4367816
Operating income: -1200854022.9885058
Net income: -1077157040.229885
Capital expenditures: 109256752.87356322
Operating cash flow: -561978448.2758621
Depreciation & amortization: 512366666.6666667
Net tangible assets: 1176136206.8965518
Owner earnings: -674047126.4367815
Return on net tangible assets (%): -57.31029471623672
Buffett classification: The Gruesome
Stock price: 23.979460847240052
Shares outstanding: 338805755
Book value: 2189595833.333333
P/B ratio: 3.71044702093443
Market cap (USD): 8124379336.842106
Debt to equity: 1.0199241619868047
Current ratio: 1.4305452559361493
Quick ratio: 1.404953454560601
Interest coverage ratio: -33.30879991072958
COGS to revenue (%): 82.42264192058082
R&D to revenue (%): 21.760462395670118
SG&A to revenue (%): 33.98247522382929
Free cash flow (dilution-adjusted): -1104939224.137931
Buyback yield (%): 0.6146906339553808
Retained earnings: -3086188074.7126436
Inventory turnover: 41.26147157053019
Receivables turnover: 7.230781650813923
Capitalized R&D asset: 684678160.9195403
ROCI (R&D-adjusted, %): -17.561334691589913
FCF margin (%): -35.117212449222386
Rule of 40 score: -35.117212449222386
Financial ratios for 9626.HK — annual report dated 2023-12-31
Total revenue: 3168493248.9451475
Gross profit: 765381856.5400844
Operating income: -712262587.90436
Net income: -676752883.2630098
Capital expenditures: 25583263.009845287
Operating cash flow: 37499578.05907173
Depreciation & amortization: 407832067.51054853
Net tangible assets: 1130694374.1209564
Owner earnings: -294504078.7623066
Return on net tangible assets (%): -26.046302652851256
Buffett classification: The Gruesome
Stock price: 11.984635083226632
Shares outstanding: 338805755
Book value: 2025916596.3431787
P/B ratio: 2.004259871853218
Market cap (USD): 4060463337.7720866
Debt to equity: 0.5307387734481733
Current ratio: 1.0344318659809502
Quick ratio: 1.0241302673294044
Interest coverage ratio: -30.705627338155672
COGS to revenue (%): 75.84398020116045
R&D to revenue (%): 19.830755406597138
SG&A to revenue (%): 26.804800624219112
Free cash flow (dilution-adjusted): -308884106.8917018
Buyback yield (%): 0
Retained earnings: -3700529676.511955
Inventory turnover: 91.61606889118859
Receivables turnover: 8.988931015660413
Capitalized R&D asset: 1087070514.0889473
ROCI (R&D-adjusted, %): -16.27672377260021
Rosenberg metric: 0.3101051592154605
FCF margin (%): -9.748611804507878
Revenue growth (%): 0.7011500147847011
Rule of 40 score: -9.047461789723176
Financial ratios for 9626.HK — annual report dated 2024-12-31
Total revenue: 3675551369.8630137
Gross profit: 1201912739.7260275
Operating income: -184105342.46575344
Net income: -184493150.68493152
Capital expenditures: 63748904.10958904
Operating cash flow: 823952602.7397261
Depreciation & amortization: 342625342.46575344
Net tangible assets: 1120856849.3150685
Owner earnings: 94383287.67123288
Buffett classification: The Gruesome
Stock price: 18.427835051546392
Shares outstanding: 338805755
Book value: 1932042876.7123284
P/B ratio: 3.2315310611940724
Market cap (USD): 6243456567.654639
Debt to equity: 0.358100124412282
Current ratio: 1.3382319739686293
Quick ratio: 1.3209462999675603
Interest coverage ratio: -15.068099514535895
COGS to revenue (%): 67.29979753293934
R&D to revenue (%): 13.734642365650107
SG&A to revenue (%): 23.97447778313011
Free cash flow (dilution-adjusted): 585718219.1780822
Buyback yield (%): 0.25785461821412226
Retained earnings: -3789240958.9041095
Inventory turnover: 70.76263103238827
Receivables turnover: 12.696145001324906
Capitalized R&D asset: 1151752846.7226996
ROCI (R&D-adjusted, %): -7.903891730701906
Rosenberg metric: 0.6947410009361127
FCF margin (%): 15.935519878202973
Revenue growth (%): 16.00313085996556
Rule of 40 score: 31.938650738168533
Financial ratios for 9626.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.427835051546392
Shares outstanding: 338805755
Market cap (USD): 6243456567.654639
Buyback yield (%): 0
Retained earnings: -3789240958.9041095
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9626.HK — quarterly report dated 2025-03-31
Total revenue: 964634710.7438017
Gross profit: 349738016.52892566
Operating income: 2067217.6308539945
Net income: -1253719.008264463
Capital expenditures: 4917217.630853995
Operating cash flow: 179351928.37465566
Depreciation & amortization: 73608402.20385675
Net tangible assets: 1165527823.6914601
Owner earnings: 67437465.56473829
Capex to operating income (%): 237.8664712153518
Buffett classification: The Gruesome
Stock price: 19.113110539845756
Shares outstanding: 338805755
Book value: 1980764187.3278236
P/B ratio: 3.2692593536774996
Market cap (USD): 6475631846.850899
Debt to equity: 0.36842182122435424
Current ratio: 1.3624426232840114
Quick ratio: 1.3469679823806733
Effective tax rate (%): 1272.008781558727
Interest coverage ratio: 0.4607779926928863
COGS to revenue (%): 63.74399421525555
R&D to revenue (%): 12.015524796494425
SG&A to revenue (%): 24.026180423711967
Free cash flow (dilution-adjusted): 85929201.10192838
Buyback yield (%): 0
Retained earnings: -3811372038.5674934
Inventory turnover: 19.09870326558028
Receivables turnover: 3.296848497687392
Capitalized R&D asset: 115905922.86501378
ROCI (R&D-adjusted, %): 3.028800083853959
FCF margin (%): 8.907952424360811
Rule of 40 score: 8.907952424360811
Financial ratios for 9626.HK — quarterly report dated 2025-06-30
Total revenue: 1023387726.6387727
Gross profit: 373200278.9400279
Operating income: 35092329.14923292
Net income: 30544211.9944212
Capital expenditures: 20146164.57461646
Operating cash flow: 277442817.2942817
Depreciation & amortization: 74202092.05020921
Net tangible assets: 1174072245.4672246
Owner earnings: 84600139.47001395
Return on net tangible assets (%): 7.205701335384786
Capex to operating income (%): 57.40902659650573
Buffett classification: The Good
Stock price: 21.363057324840764
P/E ratio: 59.241393814423326
Shares outstanding: 338805755
Book value: 1974303765.6903768
P/B ratio: 3.666065421052362
Market cap (USD): 7237926766.050955
Debt to equity: 0.7094131589421068
Current ratio: 1.5967472358173478
Quick ratio: 1.583689296041205
Effective tax rate (%): 10.773790058862
Interest coverage ratio: 7.086464259561764
COGS to revenue (%): 63.532855707995296
R&D to revenue (%): 11.807721503633976
SG&A to revenue (%): 21.230387219956143
Free cash flow (dilution-adjusted): 183932914.92329147
Buyback yield (%): 0
Retained earnings: -3828669316.596932
Inventory turnover: 22.293313694922386
Receivables turnover: 3.2737186205185798
Capitalized R&D asset: 198495740.9834365
ROCI (R&D-adjusted, %): 2.2815910880178913
Rosenberg metric: 0.20242505155173846
FCF margin (%): 17.972945163941237
Revenue growth (%): 6.090700991846776
Rule of 40 score: 24.063646155788014
Financial ratios for 9626.HK — quarterly report dated 2025-09-30
Total revenue: 1079418679.775281
Gross profit: 395776404.494382
Operating income: 49711797.75280899
Net income: 66043539.32584269
Capital expenditures: 0
Net tangible assets: 1297001123.5955057
Owner earnings: 66043539.32584269
Return on net tangible assets (%): 5.092018667089421
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 28.868894601542415
P/E ratio: 102.59660054534274
Shares outstanding: 338805755
Book value: 2091523735.9550562
P/B ratio: 4.676469821187428
Market cap (USD): 9780947631.491003
Debt to equity: 0.6508619025334266
Current ratio: 1.6386925164032937
Quick ratio: 1.6386925164032937
Effective tax rate (%): -3.246517582004263
Interest coverage ratio: 8.400332265337605
COGS to revenue (%): 63.334300961256574
R&D to revenue (%): 11.769456640271807
SG&A to revenue (%): 20.29081924948939
Buyback yield (%): 0
Receivables turnover: 6.76586493555427
Capitalized R&D asset: 246252645.7133984
ROCI (R&D-adjusted, %): 1.5672859636497098
Rosenberg metric: 0.18682849102705995
Revenue growth (%): 5.475046424539111
Rule of 40 score: 5.475046424539111
Financial ratios for 9626.HK — annual report dated 2025-12-31
Total revenue: 4335395142.857142
Gross profit: 1587730285.7142856
Operating income: 160635857.14285713
Net income: 170504428.57142857
Capital expenditures: 73265428.57142857
Operating cash flow: 1021015428.5714285
Depreciation & amortization: 312499571.4285714
Net tangible assets: 1377936285.7142856
Owner earnings: 409738571.42857146
Return on net tangible assets (%): 29.735668889521538
Capex to operating income (%): 45.60963527979432
Buffett classification: The Good
Stock price: 24.67866323907455
P/E ratio: 49.038451383112616
Shares outstanding: 338805755
Book value: 2221223285.714286
P/B ratio: 3.764265026789793
Market cap (USD): 8361273131.105398
Debt to equity: 0.6293842717169426
Current ratio: 1.3553433234555083
Quick ratio: 1.3448902376797927
Effective tax rate (%): 1.4191870446309283
Interest coverage ratio: 7.467862550806259
COGS to revenue (%): 63.37749539784906
R&D to revenue (%): 11.643321620444814
SG&A to revenue (%): 21.273964614067474
Free cash flow (dilution-adjusted): 744286857.1428571
Buyback yield (%): 1.405652305917323
Retained earnings: -3782055857.142857
Inventory turnover: 90.51983245481928
Receivables turnover: 13.514251794165688
Capitalized R&D asset: 1050366898.1330559
ROCI (R&D-adjusted, %): 2.965488740137559
Rosenberg metric: 0.7642617459160538
FCF margin (%): 17.167682128562607
Revenue growth (%): 17.95223917707674
Rule of 40 score: 35.11992130563935
Financial ratios for 9626.HK — quarterly report dated 2025-12-31
Total revenue: 1188766714.2857144
Gross profit: 440177142.85714287
Operating income: 71983285.71428572
Net income: 73419142.85714285
Capital expenditures: 0
Net tangible assets: 1377936285.7142856
Owner earnings: 73419142.85714285
Return on net tangible assets (%): 5.328195767708107
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.67866323907455
P/E ratio: 49.54735294743252
Shares outstanding: 338805755
Book value: 2221223285.714286
P/B ratio: 3.764265026789793
Market cap (USD): 8361273131.105398
Debt to equity: 0.6293842717169426
Current ratio: 1.3553433234555083
Quick ratio: 1.3448902376797927
Effective tax rate (%): -1.1892245232272876
Interest coverage ratio: 12.484712586719525
COGS to revenue (%): 62.97194920017348
R&D to revenue (%): 11.06861408708449
SG&A to revenue (%): 19.904145556853816
Buyback yield (%): 0
Retained earnings: -3782055857.142857
Inventory turnover: 24.66174228162651
Receivables turnover: 3.7056121003984663
Capitalized R&D asset: 256574743.01278734
ROCI (R&D-adjusted, %): 2.383445601380391
Rosenberg metric: 0.3494973197811225
Revenue growth (%): 10.130270724349339
Rule of 40 score: 10.130270724349339
Financial ratios for AARD — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -10470000
Net income: -9310000
Capital expenditures: 0
Operating cash flow: -11388000
Depreciation & amortization: 5000
Net tangible assets: 150689000
Owner earnings: -9305000
Return on net tangible assets (%): -6.174969639456098
Buffett classification: The Gruesome
Stock price: 7.51
Shares outstanding: 21884158
Book value: 150689000
P/B ratio: 1.0906570922894172
Market cap (USD): 164350026.57999998
Debt to equity: 0.0048178699175122274
Current ratio: 25.86244979919679
Quick ratio: 25.86244979919679
Free cash flow (dilution-adjusted): -11621000
Buyback yield (%): 0
Retained earnings: -67637000
Capitalized R&D asset: 7755000
ROCI (R&D-adjusted, %): -3.337447419460467
Rule of 40 score: 0
Financial ratios for AARD — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -15848000
Net income: -14367000
Capital expenditures: 91000
Operating cash flow: -9844000
Depreciation & amortization: 11000
Net tangible assets: 136925000
Owner earnings: -14447000
Return on net tangible assets (%): -10.55103158663502
Buffett classification: The Gruesome
Stock price: 13.52
Shares outstanding: 21884158
Book value: 136925000
P/B ratio: 2.1608458364798246
Market cap (USD): 295873816.15999997
Debt to equity: 0.0047106079970786925
Current ratio: 14.041513094083415
Quick ratio: 14.041513094083415
Free cash flow (dilution-adjusted): -10569000
Buyback yield (%): 0
Retained earnings: -82004000
Capitalized R&D asset: 18340850
ROCI (R&D-adjusted, %): -6.2182012230836765
Rule of 40 score: 0
Financial ratios for AARD — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -17703000
Net income: -16316000
Capital expenditures: 4000
Operating cash flow: -16130000
Depreciation & amortization: 10000
Net tangible assets: 122377000
Owner earnings: -16310000
Return on net tangible assets (%): -13.327667780710428
Buffett classification: The Gruesome
Stock price: 13.29
Shares outstanding: 21884158
Book value: 122377000
P/B ratio: 2.3765941297792885
Market cap (USD): 290840459.82
Debt to equity: 0.004453451220409064
Current ratio: 12.034929210134129
Quick ratio: 12.034929210134129
Free cash flow (dilution-adjusted): -17634000
Buyback yield (%): 0
Retained earnings: -98320000
Capitalized R&D asset: 25103300
ROCI (R&D-adjusted, %): -10.509522709354277
Rule of 40 score: 0
Financial ratios for AARD — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -18704000
Net income: -17598000
Capital expenditures: 0
Operating cash flow: -16810000
Depreciation & amortization: 10000
Net tangible assets: 106633000
Owner earnings: -17588000
Return on net tangible assets (%): -16.493955904832465
Buffett classification: The Gruesome
Stock price: 13.13
Shares outstanding: 21884158
Book value: 106633000
P/B ratio: 2.694653573846746
Market cap (USD): 287338994.54
Debt to equity: 0.004135680324102295
Current ratio: 10.607318923018582
Quick ratio: 10.607318923018582
Free cash flow (dilution-adjusted): -18391000
Buyback yield (%): 0
Retained earnings: -115918000
Capitalized R&D asset: 27840640
ROCI (R&D-adjusted, %): -13.483683493657194
Rule of 40 score: 0
Financial ratios for AARD — annual report dated 2025-12-31
Total revenue: 0
Operating income: -62725000
Net income: -57591000
Capital expenditures: 95000
Operating cash flow: -54172000
Depreciation & amortization: 36000
Net tangible assets: 106633000
Owner earnings: -57650000
Return on net tangible assets (%): -54.06393893072501
Buffett classification: The Gruesome
Stock price: 13.13
Shares outstanding: 21884158
Book value: 106633000
P/B ratio: 2.694653573846746
Market cap (USD): 287338994.54
Debt to equity: 0.004135680324102295
Current ratio: 10.607318923018582
Quick ratio: 10.607318923018582
Free cash flow (dilution-adjusted): -58215000
Buyback yield (%): 0
Retained earnings: -115918000
Capitalized R&D asset: 62047610
ROCI (R&D-adjusted, %): -22.161409067704938
Rule of 40 score: 0
Financial ratios for ABBN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 981318681.3186812
Buffett classification: The Gruesome
Stock price: 32.94505494505494
Shares outstanding: 1814766523
Market cap (USD): 59787582812.68131
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABBN.SW — annual report dated 2022-12-31
Total revenue: 32006521739.130432
Gross profit: 10554347826.086956
Operating income: 3708695652.173913
Net income: 2819565217.391304
Capital expenditures: 690217391.3043478
Operating cash flow: 1398913043.4782608
Depreciation & amortization: 884782608.6956521
Net tangible assets: 934782608.6956521
Owner earnings: 3014130434.782608
Return on net tangible assets (%): 322.4418604651162
Capex to operating income (%): 18.61078546307151
Buffett classification: The Great
Stock price: 28.065217391304348
P/E ratio: 18.063713039267544
Shares outstanding: 1814766523
Book value: 14426086956.521744
P/B ratio: 3.530535836638034
Market cap (USD): 50931816982.45652
Debt to equity: 0.6441380349608196
Current ratio: 1.1839796720914755
Quick ratio: 0.8192873132070904
Effective tax rate (%): 22.30406599882145
Interest coverage ratio: 26.24615384615385
COGS to revenue (%): 67.02438361746927
R&D to revenue (%): 3.9597908035047205
SG&A to revenue (%): 17.428513210622835
Free cash flow (dilution-adjusted): 570652173.9130435
Buyback yield (%): 7.582601113699483
Retained earnings: 21828260869.565216
Inventory turnover: 3.274054412740544
Receivables turnover: 3.7693292370711724
Capitalized R&D asset: 1267391304.347826
ROCI (R&D-adjusted, %): 17.613341741994255
FCF margin (%): 1.7829246756775115
Rule of 40 score: 1.7829246756775115
Financial ratios for ABBN.SW — annual report dated 2023-12-31
Total revenue: 38375000000
Gross profit: 13350000000
Operating income: 5183333333.333334
Net income: 4552380952.380953
Capital expenditures: 741666666.6666667
Operating cash flow: 5107142857.142858
Depreciation & amortization: 928571428.5714287
Net tangible assets: 1935714285.7142859
Owner earnings: 4739285714.285714
Return on net tangible assets (%): 244.83394833948338
Capex to operating income (%): 14.308681672025722
Buffett classification: The Great
Stock price: 42.04761904761905
P/E ratio: 16.761912550303347
Shares outstanding: 1814766523
Book value: 16840476190.476189
P/B ratio: 4.531143333264528
Market cap (USD): 76306611419.4762
Debt to equity: 0.6180545737310902
Current ratio: 1.1817929349033547
Quick ratio: 0.8402577205065541
Effective tax rate (%): 19.464210966931766
Interest coverage ratio: 15.832727272727272
COGS to revenue (%): 65.21172638436482
R&D to revenue (%): 4.085621219171708
SG&A to revenue (%): 17.195594850317978
Free cash flow (dilution-adjusted): 4190476190.4761906
Buyback yield (%): 1.962633407197533
Retained earnings: 23480952380.95238
Inventory turnover: 3.4186046511627906
Receivables turnover: 3.776358950328022
Capitalized R&D asset: 2417009316.7701864
ROCI (R&D-adjusted, %): 19.534864248767327
Rosenberg metric: 2.205831903945112
FCF margin (%): 10.919807662478673
Revenue growth (%): 19.897439380561035
Rule of 40 score: 30.817247043039707
Financial ratios for ABBN.SW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.36904761904762
Shares outstanding: 1814766523
Market cap (USD): 102296660552.44048
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABBN.SW — annual report dated 2024-12-31
Total revenue: 33981111111.11111
Gross profit: 13334444444.444445
Operating income: 5281111111.111111
Net income: 4391111111.111111
Capital expenditures: 768888888.8888888
Operating cash flow: 5194444444.444445
Depreciation & amortization: 845555555.5555556
Net tangible assets: 5132222222.222222
Owner earnings: 4467777777.777777
Return on net tangible assets (%): 87.05347477809048
Capex to operating income (%): 14.559225752156532
Buffett classification: The Great
Stock price: 52.699999999999996
P/E ratio: 21.779953488332488
Shares outstanding: 1814766523
Book value: 16656666666.666664
P/B ratio: 5.741736787798679
Market cap (USD): 95638195762.09999
Debt to equity: 0.5141751717697286
Current ratio: 1.4166097993721851
Quick ratio: 1.062645011600928
Effective tax rate (%): 24.314442413162705
Interest coverage ratio: 64.22972972972973
COGS to revenue (%): 60.7592453323742
R&D to revenue (%): 4.146094235359513
SG&A to revenue (%): 19.553346630480988
Free cash flow (dilution-adjusted): 4306666666.666667
Buyback yield (%): 1.448747066498541
Retained earnings: 22942222222.22222
Inventory turnover: 3.582417582417583
Receivables turnover: 4.666310649984742
Capitalized R&D asset: 2877592305.037957
ROCI (R&D-adjusted, %): 16.821807252876848
Rosenberg metric: -0.009921538850923681
FCF margin (%): 12.67370761534186
Revenue growth (%): -11.449873326094826
Rule of 40 score: 1.2238342892470335
Financial ratios for ABBN.SW — quarterly report dated 2024-12-31
Total revenue: 8884444444.444445
Gross profit: 3313333333.333333
Operating income: 1176666666.6666667
Net income: 1105555555.5555556
Capital expenditures: 255555555.55555555
Operating cash flow: 1707777777.7777777
Depreciation & amortization: 215555555.55555555
Net tangible assets: 5132222222.222222
Owner earnings: 1065555555.5555556
Return on net tangible assets (%): 20.762069712058885
Capex to operating income (%): 21.718602455146364
Buffett classification: The Great
Stock price: 52.699999999999996
P/E ratio: 21.626727684896984
Shares outstanding: 1814766523
Book value: 16656666666.666664
P/B ratio: 5.741736787798679
Market cap (USD): 95638195762.09999
Debt to equity: 0.5141751717697286
Current ratio: 1.4166097993721851
Quick ratio: 1.062645011600928
Effective tax rate (%): 18.626609442060087
Interest coverage ratio: 264.75000000000006
COGS to revenue (%): 62.706353176588294
R&D to revenue (%): 4.477238619309655
SG&A to revenue (%): 19.572286143071533
Free cash flow (dilution-adjusted): 1406666666.6666667
Buyback yield (%): 0.46936151953922256
Retained earnings: 22942222222.22222
Inventory turnover: 0.9666473877000192
Receivables turnover: 1.2200183094293562
Capitalized R&D asset: 397777777.7777778
ROCI (R&D-adjusted, %): 4.992561813891454
FCF margin (%): 15.832916458229116
Rule of 40 score: 15.832916458229116
Financial ratios for ABBN.SW — quarterly report dated 2025-03-31
Total revenue: 8388636363.636364
Gross profit: 3547727272.7272725
Operating income: 1460227272.7272727
Net income: 1270454545.4545455
Capital expenditures: 22727272.727272727
Operating cash flow: 777272727.2727273
Depreciation & amortization: 211363636.36363637
Net tangible assets: 1413636363.6363637
Owner earnings: 1459090909.0909092
Return on net tangible assets (%): 103.2154340836013
Capex to operating income (%): 1.5564202334630348
Buffett classification: The Great
Stock price: 50.63636363636364
P/E ratio: 18.082736195187834
Shares outstanding: 1814766523
Book value: 16035227272.727276
P/B ratio: 5.730706276300758
Market cap (USD): 91893177573.72728
Debt to equity: 0.6168946212174897
Current ratio: 1.27985853432282
Quick ratio: 0.9279336734693877
Effective tax rate (%): 29.619746497665112
Interest coverage ratio: 29.883720930232556
COGS to revenue (%): 57.70793822812246
R&D to revenue (%): 4.104578704958006
SG&A to revenue (%): 20.780276347873205
Free cash flow (dilution-adjusted): 569318181.8181819
Buyback yield (%): 0.3573813634266846
Retained earnings: 22594318181.81818
Inventory turnover: 0.7018121911037891
Receivables turnover: 0.9764550264550266
Capitalized R&D asset: 610829292.9292929
ROCI (R&D-adjusted, %): 5.320895932878837
Rosenberg metric: 0.5892585068562725
FCF margin (%): 6.786778650772149
Revenue growth (%): -5.580631224703259
Rule of 40 score: 1.20614742606889
Financial ratios for ABBN.SW — quarterly report dated 2025-06-30
Total revenue: 10368750000
Gross profit: 4202500000
Operating income: 1713750000
Net income: 1476250000
Capital expenditures: 240000000
Operating cash flow: 1323750000
Depreciation & amortization: 252500000
Net tangible assets: 1913750000
Owner earnings: 1488750000
Return on net tangible assets (%): 77.79229261920314
Capex to operating income (%): 14.00437636761488
Buffett classification: The Great
Stock price: 58.27499999999999
P/E ratio: 27.452850107420016
Shares outstanding: 1814766523
Book value: 18250000000
P/B ratio: 5.794822965908218
Market cap (USD): 105755519127.82498
Debt to equity: 0.6636986301369863
Current ratio: 1.3748490817817882
Quick ratio: 0.9684183770731397
Effective tax rate (%): 26.631509558338827
Interest coverage ratio: 228.5
COGS to revenue (%): 59.469559975889084
R&D to revenue (%): 3.8577456298975283
SG&A to revenue (%): 20.144665461121157
Free cash flow (dilution-adjusted): 1071250000
Buyback yield (%): 0.583893876265349
Retained earnings: 25156250000
Inventory turnover: 0.7712632895559725
Receivables turnover: 1.0435274877343061
Capitalized R&D asset: 761959848.4848485
ROCI (R&D-adjusted, %): 5.010345216123
Rosenberg metric: 1.9016501650165023
FCF margin (%): 10.33152501506932
Revenue growth (%): 23.604714169601728
Rule of 40 score: 33.936239184671045
Financial ratios for ABBN.SW — annual report dated 2025-12-31
Total revenue: 42050632911.3924
Gross profit: 17265822784.810127
Operating income: 7251898734.177215
Net income: 6105063291.13924
Capital expenditures: 1021518987.3417721
Operating cash flow: 6922784810.126582
Depreciation & amortization: 1029113924.0506328
Net tangible assets: 6748101265.822784
Owner earnings: 6112658227.848101
Return on net tangible assets (%): 90.58338022885012
Capex to operating income (%): 14.086227962995288
Buffett classification: The Great
Stock price: 73.87341772151899
P/E ratio: 21.95931459304997
Shares outstanding: 1814766523
Book value: 21070886075.949364
P/B ratio: 6.362475927086389
Market cap (USD): 134063005420.6076
Debt to equity: 0.5460771356482038
Current ratio: 1.5576396078192558
Quick ratio: 1.2124109372145424
Effective tax rate (%): 25.245216272712657
Interest coverage ratio: 66.61627906976744
COGS to revenue (%): 58.94039735099338
R&D to revenue (%): 3.967489464178206
SG&A to revenue (%): 19.846478025285975
Free cash flow (dilution-adjusted): 5655696202.531646
Buyback yield (%): 1.4153556743542233
Retained earnings: 28615189873.41772
Inventory turnover: 3.4538719350855533
Receivables turnover: 4.638369170622731
Capitalized R&D asset: 3129702843.0781593
ROCI (R&D-adjusted, %): 18.825002033440892
Rosenberg metric: 2.7904104939504055
FCF margin (%): 13.449729078868152
Revenue growth (%): 23.747080470369692
Rule of 40 score: 37.19680954923784
Financial ratios for ABBN.SW — quarterly report dated 2025-12-31
Total revenue: 11458227848.101265
Gross profit: 4630379746.835443
Operating income: 1924050632.9113922
Net income: 1620253164.556962
Capital expenditures: 494936708.8607595
Operating cash flow: 2467088607.5949364
Depreciation & amortization: 279746835.443038
Net tangible assets: 6748101265.822784
Owner earnings: 1405063291.1392405
Return on net tangible assets (%): 20.821609454136187
Capex to operating income (%): 25.723684210526322
Buffett classification: The Good
Stock price: 73.87341772151899
P/E ratio: 24.497520410618126
Shares outstanding: 1814766523
Book value: 21070886075.949364
P/B ratio: 6.362475927086389
Market cap (USD): 134063005420.6076
Debt to equity: 0.5460771356482038
Current ratio: 1.5576396078192558
Quick ratio: 1.2124109372145424
Effective tax rate (%): 18.646232439335886
Interest coverage ratio: 116.92307692307692
COGS to revenue (%): 59.589041095890416
R&D to revenue (%): 4.076447193990278
SG&A to revenue (%): 19.542642509942556
Free cash flow (dilution-adjusted): 1949367088.607595
Buyback yield (%): 0.33046997066309414
Retained earnings: 28615189873.41772
Inventory turnover: 0.9514905627094726
Receivables turnover: 1.2638927673834126
Capitalized R&D asset: 848713607.5949367
ROCI (R&D-adjusted, %): 5.38879022395999
Rosenberg metric: 1.0696993670886064
FCF margin (%): 17.012814847547507
Revenue growth (%): 10.507321018457045
Rule of 40 score: 27.52013586600455
Financial ratios for ACCO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.22
Shares outstanding: 92257794
Market cap (USD): 573843478.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACCO — annual report dated 2022-12-31
Total revenue: 1947600000
Gross profit: 552300000
Operating income: 134100000
Net income: -13200000
Capital expenditures: 16500000
Operating cash flow: 77600000
Depreciation & amortization: 79400000
Net tangible assets: -708400000
Owner earnings: 49700000
Capex to operating income (%): 12.304250559284116
Buffett classification: The Great
Stock price: 4.4
Shares outstanding: 92257794
Book value: 810100000
P/B ratio: 0.5010915857301569
Market cap (USD): 405934293.6
Debt to equity: 1.34909270460437
Current ratio: 1.497962648556876
Quick ratio: 0.8269949066213922
Effective tax rate (%): 188.59060402684565
Interest coverage ratio: 2.9407894736842106
COGS to revenue (%): 71.64202094886014
SG&A to revenue (%): 19.341753953583897
Free cash flow (dilution-adjusted): 51600000
Buyback yield (%): 4.779098564930903
Retained earnings: -504400000
Inventory turnover: 3.5306174089068825
Receivables turnover: 5.070554543087738
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.079702588747336
FCF margin (%): 2.649414664202095
Rule of 40 score: 2.649414664202095
Financial ratios for ACCO — annual report dated 2023-12-31
Total revenue: 1832800000
Gross profit: 598300000
Operating income: 161400000
Net income: -21800000
Capital expenditures: 13800000
Operating cash flow: 128700000
Depreciation & amortization: 76100000
Net tangible assets: -618700000
Owner earnings: 40500000
Capex to operating income (%): 8.550185873605948
Buffett classification: The Great
Stock price: 5.08
Shares outstanding: 92257794
Book value: 787000000
P/B ratio: 0.5955140959593394
Market cap (USD): 468669593.52
Debt to equity: 1.2912325285895807
Current ratio: 1.578228782287823
Quick ratio: 0.9739852398523985
Interest coverage ratio: 2.7542662116040955
COGS to revenue (%): 67.35595809690092
SG&A to revenue (%): 21.469882147533827
Free cash flow (dilution-adjusted): 100100000
Buyback yield (%): 0
Retained earnings: -556000000
Inventory turnover: 3.769465648854962
Receivables turnover: 4.2553981889946595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.675480311965
FCF margin (%): 5.461588825840245
Revenue growth (%): -5.894434175395358
Rule of 40 score: -0.4328453495551132
Financial ratios for ACCO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.77
Shares outstanding: 92257794
Market cap (USD): 440069677.37999994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACCO — annual report dated 2024-12-31
Total revenue: 1666200000
Gross profit: 555400000
Operating income: 145000000
Net income: -101600000
Capital expenditures: 15900000
Operating cash flow: 148200000
Depreciation & amortization: 73100000
Net tangible assets: -549900000
Owner earnings: -44400000
Capex to operating income (%): 10.965517241379311
Buffett classification: The Great
Stock price: 4.64
Shares outstanding: 92257794
Book value: 606100000
P/B ratio: 0.7062797626794258
Market cap (USD): 428076164.15999997
Debt to equity: 1.5228510146840455
Current ratio: 1.491943707933918
Quick ratio: 0.9404446257393433
Interest coverage ratio: 2.7566539923954374
COGS to revenue (%): 66.66666666666666
SG&A to revenue (%): 21.948145480734603
Free cash flow (dilution-adjusted): 120400000
Buyback yield (%): 3.5040493388446463
Retained earnings: -687600000
Inventory turnover: 4.1079881656804735
Receivables turnover: 4.775580395528805
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.34244289741672
FCF margin (%): 7.226023286520225
Revenue growth (%): -9.089917066783064
Rule of 40 score: -1.8638937802628393
Financial ratios for ACCO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.64
Shares outstanding: 92257794
Market cap (USD): 428076164.15999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACCO — quarterly report dated 2025-03-31
Total revenue: 317400000
Gross profit: 99600000
Operating income: -4400000
Net income: -13200000
Capital expenditures: 2200000
Operating cash flow: 5500000
Depreciation & amortization: 18000000
Net tangible assets: -576200000
Owner earnings: 2600000
Buffett classification: The Gruesome
Stock price: 3.76
Shares outstanding: 92257794
Book value: 606100000
P/B ratio: 0.5723301525160864
Market cap (USD): 346889305.44
Debt to equity: 1.6883352582082165
Current ratio: 1.7624584717607974
Quick ratio: 1.0156620787850024
Interest coverage ratio: -0.4074074074074074
COGS to revenue (%): 68.62003780718337
SG&A to revenue (%): 29.206049149338376
Free cash flow (dilution-adjusted): -4500000
Buyback yield (%): 4.324145992616796
Retained earnings: -708500000
Inventory turnover: 0.6920877025738799
Receivables turnover: 1.2881493506493507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.23819835426591596
FCF margin (%): -1.4177693761814745
Rule of 40 score: -1.4177693761814745
Financial ratios for ACCO — quarterly report dated 2025-06-30
Total revenue: 394800000
Gross profit: 129700000
Operating income: 35500000
Net income: 29200000
Capital expenditures: 4600000
Operating cash flow: -38900000
Depreciation & amortization: 18200000
Net tangible assets: -554000000
Owner earnings: 42800000
Return on net tangible assets (%): -7.725631768953069
Capex to operating income (%): 12.957746478873238
Buffett classification: The Great
Stock price: 3.28
P/E ratio: 18.91284777
Shares outstanding: 92257794
Book value: 637300000
P/B ratio: 0.4748243595167111
Market cap (USD): 302605564.32
Debt to equity: 1.6849207594539464
Current ratio: 1.8456612938838595
Quick ratio: 1.1527931110620446
Effective tax rate (%): -28.634361233480178
Interest coverage ratio: 2.9831932773109244
COGS to revenue (%): 67.14792299898683
SG&A to revenue (%): 20.921985815602838
Free cash flow (dilution-adjusted): -44000000
Buyback yield (%): 0.03304631896796576
Retained earnings: -686400000
Inventory turnover: 0.8448056086679414
Receivables turnover: 1.1318807339449541
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8444432898633554
FCF margin (%): -11.144883485309018
Revenue growth (%): 24.38563327032136
Rule of 40 score: 13.240749785012342
Financial ratios for ACCO — quarterly report dated 2025-09-30
Total revenue: 383700000
Gross profit: 126600000
Operating income: 27500000
Net income: 4000000
Capital expenditures: 5500000
Operating cash flow: 71500000
Depreciation & amortization: 18400000
Net tangible assets: -537300000
Owner earnings: 16900000
Return on net tangible assets (%): -3.1453564116880703
Capex to operating income (%): 20
Buffett classification: The Great
Stock price: 3.73
P/E ratio: 17.206078581
Shares outstanding: 92257794
Book value: 644000000
P/B ratio: 0.5343502664906833
Market cap (USD): 344121571.62
Debt to equity: 1.494254658385093
Current ratio: 1.6777370590929912
Quick ratio: 0.9555657352267521
Effective tax rate (%): 72.78911564625851
Interest coverage ratio: 2.2
COGS to revenue (%): 67.00547302580141
SG&A to revenue (%): 22.778212144904874
Free cash flow (dilution-adjusted): 65400000
Buyback yield (%): 0
Retained earnings: -689200000
Inventory turnover: 0.8154138915318744
Receivables turnover: 1.2945344129554657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5094132499039463
FCF margin (%): 17.04456606724003
Revenue growth (%): -2.811550151975684
Rule of 40 score: 14.233015915264346
Financial ratios for ACCO — quarterly report dated 2025-12-31
Total revenue: 428800000
Gross profit: 144100000
Operating income: 48500000
Net income: 21300000
Capital expenditures: 5600000
Operating cash flow: 30600000
Depreciation & amortization: 18200000
Net tangible assets: -510800000
Owner earnings: 33900000
Return on net tangible assets (%): -6.63664839467502
Capex to operating income (%): 11.54639175257732
Buffett classification: The Great
Stock price: 3.57
P/E ratio: 7.974826261016949
Shares outstanding: 92257794
Book value: 664600000
P/B ratio: 0.4955767748721035
Market cap (USD): 329360324.58
Debt to equity: 1.3854950346072825
Current ratio: 1.61250805931657
Quick ratio: 0.9911884805501827
Effective tax rate (%): 24.46808510638298
Interest coverage ratio: 4.5754716981132075
COGS to revenue (%): 66.3945895522388
SG&A to revenue (%): 19.58955223880597
Free cash flow (dilution-adjusted): 22400000
Buyback yield (%): 0
Retained earnings: -675300000
Inventory turnover: 0.9847803528190937
Receivables turnover: 1.1921045315540728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7129831627230523
FCF margin (%): 5.223880597014925
Revenue growth (%): 11.753974459212927
Rule of 40 score: 16.977855056227853
Financial ratios for ACCO — annual report dated 2025-12-31
Total revenue: 1524700000
Gross profit: 500000000
Operating income: 107100000
Net income: 41300000
Capital expenditures: 17900000
Operating cash flow: 68700000
Depreciation & amortization: 72800000
Net tangible assets: -510800000
Owner earnings: 96200000
Return on net tangible assets (%): -18.833202819107285
Capex to operating income (%): 16.713352007469652
Buffett classification: The Great
Stock price: 3.57
P/E ratio: 7.974826261016949
Shares outstanding: 92257794
Book value: 664600000
P/B ratio: 0.4955767748721035
Market cap (USD): 329360324.58
Debt to equity: 1.3854950346072825
Current ratio: 1.61250805931657
Quick ratio: 0.9911884805501827
Effective tax rate (%): 15.885947046843176
Interest coverage ratio: 2.3384279475982535
COGS to revenue (%): 67.20666360595527
SG&A to revenue (%): 22.738899455630616
Free cash flow (dilution-adjusted): 39300000
Buyback yield (%): 4.58464449816641
Retained earnings: -675300000
Inventory turnover: 3.544448287789692
Receivables turnover: 4.238810119544064
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.990938076858534
FCF margin (%): 2.5775562405719157
Revenue growth (%): -8.492377865802425
Rule of 40 score: -5.914821625230509
Financial ratios for AG.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.937007874015748
Shares outstanding: 493769568
Market cap (USD): 5400361653.165355
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AG.TO — annual report dated 2022-12-31
Total revenue: 460919117.6470588
Gross profit: 12317647.058823528
Operating income: -37948529.4117647
Net income: -84026470.58823529
Capital expenditures: 43900735.294117644
Operating cash flow: 13961764.705882352
Depreciation & amortization: 101037500
Net tangible assets: 1037719117.6470587
Owner earnings: -26889705.882352933
Return on net tangible assets (%): -2.591231617985712
Buffett classification: The Gruesome
Stock price: 8.205882352941176
Shares outstanding: 493769568
Book value: 1037719117.6470587
P/B ratio: 3.90453921062738
Market cap (USD): 4051814984.4705877
Debt to equity: 0.1756857871264609
Current ratio: 2.212014408688224
Quick ratio: 1.8251482983769318
Interest coverage ratio: -3.98809983772506
COGS to revenue (%): 97.32759033261546
SG&A to revenue (%): 7.769163276700965
Free cash flow (dilution-adjusted): -156360294.11764705
Buyback yield (%): 0.012067939679116006
Retained earnings: -344776470.58823526
Inventory turnover: 9.420762495946635
Receivables turnover: 15.208899456521738
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6567350111448
FCF margin (%): -33.92358618489272
Rule of 40 score: -33.92358618489272
Financial ratios for AG.TO — annual report dated 2023-12-31
Total revenue: 436655303.030303
Gross profit: 19425757.575757574
Operating income: -42921969.696969695
Net income: -102357575.75757575
Capital expenditures: 24232575.757575758
Operating cash flow: 42131818.18181818
Depreciation & amortization: 95583333.33333333
Net tangible assets: 1028878787.8787879
Owner earnings: -31006818.18181818
Return on net tangible assets (%): -3.0136512237504784
Buffett classification: The Gruesome
Stock price: 6.113636363636363
Shares outstanding: 493769568
Book value: 1028878787.8787878
P/B ratio: 2.9339973005036377
Market cap (USD): 3018727586.181818
Debt to equity: 0.18887432627455603
Current ratio: 2.5725166059032114
Quick ratio: 2.0423762672926133
Interest coverage ratio: -3.7154567512623777
COGS to revenue (%): 95.55123745413222
SG&A to revenue (%): 8.740685479323716
Free cash flow (dilution-adjusted): -78212878.78787878
Buyback yield (%): 0
Retained earnings: -462027272.7272727
Inventory turnover: 8.64724446537918
Receivables turnover: 11.838824302674281
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.052283219041739
FCF margin (%): -17.91181241704763
Revenue growth (%): -5.264223957691293
Rule of 40 score: -23.176036374738924
Financial ratios for AG.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.985185185185185
Shares outstanding: 493769568
Market cap (USD): 2955302303.288889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AG.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.503496503496504
Shares outstanding: 493769568
Market cap (USD): 2717459091.0209794
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AG.TO — annual report dated 2024-12-31
Total revenue: 394147552.44755244
Gross profit: 64265734.26573427
Operating income: 3872027.9720279723
Net income: -71248251.74825175
Capital expenditures: 14002797.202797204
Operating cash flow: 106272727.27272728
Depreciation & amortization: 87756643.35664336
Net tangible assets: 944804895.1048951
Owner earnings: 2505594.4055944085
Capex to operating income (%): 361.639877189814
Buffett classification: The Gruesome
Stock price: 5.503496503496504
Shares outstanding: 493769568
Book value: 944804895.1048951
P/B ratio: 2.87621190904105
Market cap (USD): 2717459091.0209794
Debt to equity: 0.17542897449504874
Current ratio: 2.5558081035569997
Quick ratio: 2.1225373682496342
Interest coverage ratio: 0.3586836820625769
COGS to revenue (%): 83.69500612989704
SG&A to revenue (%): 9.15421614496009
Free cash flow (dilution-adjusted): 17242657.342657343
Buyback yield (%): 0.006973812048787396
Retained earnings: -501439160.83916086
Inventory turnover: 7.54479879726185
Receivables turnover: 12.208525570212489
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.30166479522261475
FCF margin (%): 4.374670662188559
Revenue growth (%): -9.734852705957083
Rule of 40 score: -5.360182043768524
Financial ratios for AG.TO — quarterly report dated 2025-03-31
Total revenue: 172022377.62237763
Gross profit: 44618881.11888112
Operating income: 26482517.482517485
Net income: 4363636.363636364
Capital expenditures: 10849650.34965035
Operating cash flow: 38805594.40559441
Depreciation & amortization: 43897902.0979021
Net tangible assets: 1694167832.1678321
Owner earnings: 37411888.11188811
Return on net tangible assets (%): 2.208275201637869
Capex to operating income (%): 40.969104832321094
Buffett classification: The Good
Stock price: 6.706293706293707
P/E ratio: 189.71354796153844
Shares outstanding: 493769568
Book value: 1981631468.5314684
P/B ratio: 1.6710290479448842
Market cap (USD): 3311363746.2377625
Debt to equity: 0.082844431708986
Current ratio: 3.1924732871556305
Quick ratio: 2.740783865604471
Effective tax rate (%): 78.5197934595525
Interest coverage ratio: 8.980317761441784
COGS to revenue (%): 74.06216462323978
SG&A to revenue (%): 7.26283781586393
Free cash flow (dilution-adjusted): -7256643.356643356
Buyback yield (%): 0.03011456528554976
Retained earnings: -501786013.986014
Inventory turnover: 2.184391635892763
Receivables turnover: 3.3877129439632023
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9838896193799496
FCF margin (%): -4.218429867637972
Rule of 40 score: -4.218429867637972
Financial ratios for AG.TO — quarterly report dated 2025-06-30
Total revenue: 193230656.93430656
Gross profit: 36022627.73722628
Operating income: 18197080.2919708
Net income: 41298540.145985395
Capital expenditures: 13119708.02919708
Operating cash flow: 65770802.91970802
Depreciation & amortization: 54056934.30656934
Net tangible assets: 1822631386.8613138
Owner earnings: 82235766.42335765
Return on net tangible assets (%): 4.511925286493218
Capex to operating income (%): 72.09787404733254
Buffett classification: The Good
Stock price: 8.211678832116787
P/E ratio: 88.79728080054755
Shares outstanding: 493769568
Book value: 2118554744.525547
P/B ratio: 1.913888286326583
Market cap (USD): 4054677109.4890504
Debt to equity: 0.0808063615879163
Current ratio: 3.265570643025474
Quick ratio: 2.8422327868517967
Effective tax rate (%): -48.8216108159293
Interest coverage ratio: 4.9720781810929395
COGS to revenue (%): 81.35770570325545
SG&A to revenue (%): 6.042096356232482
Free cash flow (dilution-adjusted): 27431386.861313865
Buyback yield (%): 0.05119797095312281
Retained earnings: -486997080.2919708
Inventory turnover: 2.5951296510507036
Receivables turnover: 3.400724525975027
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6395597325188289
FCF margin (%): 14.19618775639718
Revenue growth (%): 12.328790942818614
Rule of 40 score: 26.524978699215794
Financial ratios for AG.TO — quarterly report dated 2025-09-30
Total revenue: 206275539.56834534
Gross profit: 71281294.96402878
Operating income: 55302877.69784173
Net income: 30907913.66906475
Capital expenditures: 12332374.100719426
Operating cash flow: 80949640.2877698
Depreciation & amortization: 39708633.093525186
Net tangible assets: 1870172661.8705037
Owner earnings: 58284172.66187051
Return on net tangible assets (%): 3.1165129215168843
Capex to operating income (%): 22.299696894797776
Buffett classification: The Great
Stock price: 12.273381294964029
P/E ratio: 79.14607604315644
Shares outstanding: 493769568
Book value: 2163625899.2805758
P/B ratio: 2.8009565710637614
Market cap (USD): 6060222179.913669
Debt to equity: 0.07886208868672359
Current ratio: 3.3793902171528845
Quick ratio: 2.9572274621627552
Effective tax rate (%): 35.21819113966042
Interest coverage ratio: 17.761321626617377
COGS to revenue (%): 65.44365118947556
SG&A to revenue (%): 5.1241093320033615
Free cash flow (dilution-adjusted): 37861870.503597125
Buyback yield (%): 0
Retained earnings: -462269784.1726619
Inventory turnover: 1.949891927841051
Receivables turnover: 3.447308621788321
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.918154483412559
FCF margin (%): 18.35499768068833
Revenue growth (%): 6.750938407497988
Rule of 40 score: 25.10593608818632